Literature DB >> 14599946

Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.

Hai Wang1, Xiao-Ping Chen, Fa-Zu Qiu.   

Abstract

OBJECTIVE: To determine the effect of Salviae miltiorrhizae on cirrhosis and portal hypertension by inhibiting nitric oxide synthase type II (NOSII) in rats.
METHODS: Real time RT-PCR was used to detect the expression of NOSII mRNA. The enzymatic activity of nitric oxide synthase and the circulating levels of nitric oxide (NO), systemic and portal hemodynamics, and quantification of cirrhosis were measured with highly sensitive methods. Traditional Chinese medicine was utilized to treat cirrhotic rats and the function of NO was evaluated. Double-blind method was applied in the experiment constantly.
RESULTS: The concentration of NO increased markedly at all stages of cirrhosis, and so did the enzymatic activity of NOS, and the iNOSmRNA expressed greatly. Meanwhile the portal-venous-pressure (PVP), portal-venous-flow (PVF) increased significantly. NO, NOS and iNOSmRNA were positively correlated to the quantity of hepatic fibrosis. Salviae miltiorrhizae significantly inhibited NO production and inhibited the expression of iNOSmRNA.
CONCLUSIONS: The increased hepatic expression of NOSII is one of the important factors causing cirrhosis and portal hypertension. Salviae miltiorrhizae significantly ameliorates cirrhosis and portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599946

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals.

Authors:  Titiz Izzet; Krand Osman; Unal Ethem; Yavuz Nihat; Kusaslan Ramazan; Dogan Mustafa; Uzun Hafize; Kiziler Ali Riza; Aydemir Birsen; Genc Habibe; Aydin Seval; Simsek Gonul
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Effects of Salviae Miltiorrhizae Radix Hot Aqueous Extract on Nitric Oxide and Prostaglandin E2 Production and on 1,1-diphenyl-2-picryl hydrazyl Radical Scavenging in Macrophages.

Authors:  In Ho Yeo; Cham Kyul Lee; Eun Yong Lee
Journal:  J Pharmacopuncture       Date:  2014-03

3.  Qi Sui Zhu Shui Plaster Inhibits AQP1 and MAPK Signaling Reduces Liver Damage Induced by Cirrhotic Ascites.

Authors:  Rong Zhen Zhang; Yin Liu; Min Li; Yong Lin Huang; Zhen Heng Song
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

4.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

5.  Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.

Authors:  María García-Fernández; Inma Castilla-Cortázar; Matías Díaz-Sanchez; Iñigo Navarro; Juan Enrique Puche; Alberto Castilla; Amelia Díaz Casares; Encarna Clavijo; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2005-03-03       Impact factor: 3.067

Review 6.  Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.

Authors:  Florent Duval; Jorge E Moreno-Cuevas; María Teresa González-Garza; Carmen Maldonado-Bernal; Delia Elva Cruz-Vega
Journal:  Int J Inflam       Date:  2015-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.